Eu Ivdd Eu Ivd Self Testing On The Market 🇹🇼 Taiwan

HemoSmart GOLD

Apex Biotechnology Corp. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
3
Notified Bodies
1

Basic Information

Primary DI
D-47136487606A06A
Basic UDI-DI Code
B-47136487606A06A
Reference
S25009, S25032, S25033
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Self Testing
Status
On The Market

Additional Description

The HemoSmart GOLD Hemoglobin Screening System is intended for use outside the body (in vitro diagnostic use) and is useful for quantitative measurement of hemoglobin in the range of 4 g/dL to 24 g/dL in capillary (fingerstick) or venous whole blood. HemoSmart GOLD Hemoglobin Screening System is intended for selftesting for monitoring the health of the patient (e.g. anemias (low Hb), erythrocytosis (high Hb), thalassemias (aberrant chain synthesis), and sickling disorders (abnormal complex shape)) by layperson and by health care professional. It is not indicated for diagnostic use or for neonatal and children use.

CND Nomenclature Codes

Code Description
W010106010801 BLOOD TEST STRIPS CONTROLS
W0101060199 BLOOD TEST STRIPS (CC) - RAPID TESTS AND "POINT OF CARE" - OTHER
W0201069099 VARIOUS RAPID TEST CHEMISTRY / IMMUNOCHEMISTRY INSTRUMENTS - OTHER

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL2100077-1

Available In Countries

🇬🇷 Greece 🇫🇮 Finland 🇵🇱 Poland

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Self Testing) and regulation (EU IVDD).

View all